BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:29 PM
 | 
Aug 27, 2012
 |  BC Extra  |  Company News

Hold lifted on Lpath's iSONEP

FDA lifted a clinical hold on iSONEP from Lpath Inc. (OTCBB:LPTN), which will resume dosing of the ophthalmic product in the Phase IIa Nexus trial...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >